English
Chinese
French
Arabic
Spanish
CHU PHARMA Participates in CPHI China and API China, Two Major Annual Exhibitions, to Consolidate Industry Brand Influence
CHU PHARMA exhibited at both CPHI Shanghai in the first half of the year and API China in the autumn, showcasing its three major business segments: generic drug APIs, innovative GLP-1 APIs, and customized injec···
CHU PHARMA Participates in Pharmaceutical Africa, Expanding into Emerging Markets in Kenya and Tanzania
The company participated in Pharmaceutical Africa for the second time, focusing on expanding into East Africa in addition to its traditional West African market. The company specifically promoted its GLP-1 weig···
API China Showcases GLP-1 APIs, Receives Custom R&D Inquiries from Europe and America
The 90th API China Autumn Exhibition was held in Guangzhou. The company's core products were promoted as telpolide API and olfoglitazone tablet OEM, precisely targeting the formulation customization needs o···
CHU PHARMA Participates in API China, Reaches Annual Foreign Trade Framework Agreement Worth Tens of Millions of Yuan
The 86th API China Autumn Exhibition concluded successfully. CHU PHARMA showcased its full range of APIs and injectable drug manufacturing solutions. During the exhibition, it signed annual supply framework agr···
First Overseas Exhibition at Vietnam VIFA International Pharmaceutical Exhibition: Deepening the Reach of Local Formulation Manufacturers in Southeast Asia
The 2020 Vietnam Ho Chi Minh City VIFA International Pharmaceutical Exhibition was successfully held, marking the company's first independent overseas participation in a professional pharmaceutical exhibiti···
CHU PHARMA Makes its Debut at API China, Secures First Batch of Overseas Potential Clients
Published: 2019-05-22 The 83rd API China (China International Pharmaceutical Ingredients Trade Fair) concluded successfully in Shanghai. This marked CHU PHARMA's first appearance at a major industry exhibit···